Citius Oncology (CTOR) Other Non-Current Liabilities (2024 - 2026)

Citius Oncology (CTOR) has reported Other Non-Current Liabilities for 3 consecutive years, with $559015.0 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities changed 0.0% year-over-year to $559015.0 in Q1 2026; TTM through Mar 2026 was $559015.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $559015.0, changed N/A from the prior year.
• Other Non-Current Liabilities was $559015.0 for Q1 2026 at Citius Oncology, roughly flat from $559015.0 in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $559015.0 in Q4 2024 and troughed at $559015.0 in Q4 2024.
• A 3-year average of $559015.0 and a median of $559015.0 in 2024 frame the typical range for Other Non-Current Liabilities.
• The widest YoY moves for Other Non-Current Liabilities: up 0.0% in 2025, down 0.0% in 2025.
• Over 3 years, Other Non-Current Liabilities stood at $559015.0 in 2024, then changed by 0.0% to $559015.0 in 2025, then changed by 0.0% to $559015.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $559015.0 (Q1 2026), $559015.0 (Q4 2025), and $559015.0 (Q3 2025), per Business Quant data.